Skip to main content
Clinical Trials/NCT06696534
NCT06696534
Recruiting
Not Applicable

Exploring Participant Preference for Screening Methods and Experience Into Colorectal Cancer Screening Programme

ADVANCED MARKER DISCOVERY S.L.2 sites in 2 countries1,000 target enrollmentMay 19, 2025

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Screening for Colon Cancer
Sponsor
ADVANCED MARKER DISCOVERY S.L.
Enrollment
1000
Locations
2
Primary Endpoint
Value of questionnaires into screening programme
Status
Recruiting
Last Updated
7 months ago

Overview

Brief Summary

The goal of this low-risk interventional study is to analyze participants' assessment of colorectal cancer screening program through screening method preference and experience after FOBT analysis in screaned participant population for colorectal cancer; could include any of the following: both sexes, age 50-69 years, asympthomatic volunteers. The main aims to answer are:

  • Values of experience of participants into screening programme.
  • Values of preferences of participants for screening methods.

Participants will answer two questionnaires and they'll be given their information and clinical data to investigator or health personnel.

Detailed Description

Multicentre, international (Spain and Portugal), no-competitive, prospective, transversal and low-risk interventional study coming from average risk participants (50-69 years old) from the colorectal cancer screening programme who are eligible to undergo analysis for screening FOBT to analyze participants' assessment of colorectal cancer screening program through screening method preference and experience after FOBT analysis.

Registry
clinicaltrials.gov
Start Date
May 19, 2025
End Date
December 1, 2025
Last Updated
7 months ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
ADVANCED MARKER DISCOVERY S.L.
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Participants ages from 50 to 69 years (both included) at the time of informed consent signed.
  • Participants invited to participate in population-based screening programme who are eligible to undertake FOBT at the Primary Health Care Center.
  • Participants should sign an informed consent. They must understand the nature, significance, implications, and risks of the clinical study before signing the informed consent form.

Exclusion Criteria

  • Participants who have not delivery a stool sample in the Primary Health Care Center before signing the informed consent form.
  • Participants with a previous colonoscopy in consequence of a FOBT positive result.
  • Participants who are in a dependent personal or non-medical relationship with the Sponsor or the Investigators.

Outcomes

Primary Outcomes

Value of questionnaires into screening programme

Time Frame: 12 months

The percentage of number of answers from each experience and preference questions

Study Sites (2)

Loading locations...

Similar Trials